Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adaptogenic effects of curcumin on depression induced by moderate and unpredictable chronic stress in mice
Jéssica Gabriele da Silva Marques, Flavia Tasmin Techera Antunes, Lucimar Fillot da Silva Brum, et al.
Behavioural Brain Research (2020) Vol. 399, pp. 113002-113002
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Anti-Inflammatory, Antioxidant, and Neuroprotective Effects of Polyphenols—Polyphenols as an Element of Diet Therapy in Depressive Disorders
Anna Winiarska‐Mieczan, Małgorzata Kwiecień, Karolina Jachimowicz-Rogowska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2258-2258
Open Access | Times Cited: 50
Nrf2: An all-rounder in depression
Chengchao Zuo, Huấn Cao, Yu Song, et al.
Redox Biology (2022) Vol. 58, pp. 102522-102522
Open Access | Times Cited: 66
Potential Role of Curcumin for the Treatment of Major Depressive Disorder
Adrian L. Lopresti
CNS Drugs (2022) Vol. 36, Iss. 2, pp. 123-141
Open Access | Times Cited: 39
The Golden Spice for Life: Turmeric with the Pharmacological Benefits of Curcuminoids Components, Including Curcumin, Bisdemethoxycurcumin, and Demethoxycurcumins
Mohamad Hesam Shahrajabian, Wenli Sun
Current Organic Synthesis (2023) Vol. 21, Iss. 5, pp. 665-683
Closed Access | Times Cited: 20
An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders
Nicolás Lamanna‐Rama, Diego Romero‐Miguel, Manuel Desco, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 353-353
Open Access | Times Cited: 24
The Potential of Selected Plants and Their Biologically Active Molecules in the Treatment of Depression and Anxiety Disorders
Nicol Urbanská, Tolulope Joshua Ashaolu, Simona Mattova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2368-2368
Open Access
Design of Anti-depressant Phosphodiester Amino Acidic Keap1-Nrf2 Protein-Protein Interaction Inhibitors
Yi Sun, Jue Wang, Wanyu Ding, et al.
Redox Biology (2025), pp. 103620-103620
Open Access
Curcumin micronization by supercritical fluid: In vitro and in vivo biological relevance
Adrieli Sachett, Matheus Gallas‐Lopes, Radharani Benvenutti, et al.
Industrial Crops and Products (2022) Vol. 177, pp. 114501-114501
Open Access | Times Cited: 19
A comprehensive review on the impact of polyphenol supplementation and exercise on depression and brain function parameters
Jie Song, Aili Fu, Chuan Wang, et al.
Behavioral and Brain Functions (2025) Vol. 21, Iss. 1
Open Access
Curcumin Relieves Chronic Unpredictable Mild Stress-Induced Depression-Like Behavior through the PGC-1α/FNDC5/BDNF Pathway
Yanqin Wu, Fusheng Sun, Yujin Guo, et al.
Behavioural Neurology (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 23
Recent Progress in Research on Mechanisms of Action of Natural Products against Alzheimer’s Disease: Dietary Plant Polyphenols
Yi Wang, Kaiyue Wang, Junyuan Yan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13886-13886
Open Access | Times Cited: 17
Efficacy and Anti-Inflammatory Activity of Ashwagandha Sustained-Release Formulation on Depression and Anxiety Induced by Chronic Unpredictable Stress: in vivo and in vitro Studies
Alluri V. Krishnaraju, Somepalli Venkateswarlu, Shefali Thanawala, et al.
Journal of Experimental Pharmacology (2023) Vol. Volume 15, pp. 291-305
Open Access | Times Cited: 10
Polyphenols as novel interventions for depression: Exploring the efficacy, mechanisms of action, and implications for future research
Elizabeth Gamage, Rebecca Orr, Nikolaj Travica, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105225-105225
Open Access | Times Cited: 9
Mechanistic insights into the anti-depressant effect of curcumin based on network pharmacology and experimental validation
Jing Guo, Meng Fang, Zhe Xiong, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 1, pp. 583-598
Open Access | Times Cited: 8
Synergistic effects of Lacticaseibacillus rhamnosus GG, glutamine, and curcumin on chronic unpredictable mild stress-induced depression in a mouse model
P. Faucher, A. Dries, P.Y. Mousset, et al.
Beneficial Microbes (2022) Vol. 13, Iss. 3, pp. 253-264
Open Access | Times Cited: 12
Mitochondrial dysfunction and type I interferon signaling induce anxiodepressive-like behaviors in mice with neuropathic pain
Natsuki Yoshimoto, Yoki Nakamura, Kazue Hisaoka‐Nakashima, et al.
Experimental Neurology (2023) Vol. 367, pp. 114470-114470
Closed Access | Times Cited: 6
Preparation and Evaluation of Curcumin Derivatives Nanoemulsion Based on Turmeric Extract and Its Antidepressant Effect
Lin Sheng, Yumeng Wei, Chao Pi, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7965-7983
Open Access | Times Cited: 6
Review of Herbal Medicines for the Treatment of Depression
Siqi Peng, Yalan Zhou, Lu Meng, et al.
Natural Product Communications (2022) Vol. 17, Iss. 11
Open Access | Times Cited: 8
Curcumin for attention-deficit–hyperactivity disorder: a systematic review and preliminary behavioral investigation
Lélia Lilianna Borges de Sousa Macedo, Flavia Tasmin Techera Antunes, Willyane de Andrade Alvarenga, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 7, pp. 803-813
Closed Access | Times Cited: 5
Mechanistic insights into the anti-depressant effect of curcumin based on network pharmacology and experimental validation
Jing Guo, Meng Fang, Zhe Xiong, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Natural Phytochemicals for the Treatment of Major Depressive Disorder: A Mini-Review of Pre- and Clinical Studies
Gislaine Z. Réus, Luana M. Manosso, Camila O. Arent, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 2, pp. 237-254
Closed Access | Times Cited: 4
Protective Effects of Kefir Against Unpredictable Chronic Stress Alterations in Mice Central Nervous System, Heart, and Kidney
Alessandra Oliveira Silva, Jéssyca Milene Ribeiro, Talita Barbará Patrocínio, et al.
Probiotics and Antimicrobial Proteins (2022) Vol. 15, Iss. 2, pp. 411-423
Closed Access | Times Cited: 4
Curcumin and exercise prevent depression via alleviating hippocampus injury and improve depressive-like behaviors in chronically stressed depression rats
Elaheh Ahmadi, Ali Pourmotabbed, Nilofar Aghaz, et al.
Research in Pharmaceutical Sciences (2024) Vol. 19, Iss. 5, pp. 509-519
Open Access
Fluoxetine and Curcumin Prevent the Alterations in Locomotor and Exploratory Activities and Social Interaction Elicited by Immunoinflammatory Activation in Zebrafish: Involvement of BDNF and Proinflammatory Cytokines
Fernanda Petry, Amanda Rebonatto Oltramari, Ketelin Z. Kuhn, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 389-399
Closed Access | Times Cited: 1
Impact of Curcumin on Aging: Its Manifestations and Limitations
David Banji, Otilia J.F. Banji
(2023), pp. 253-291
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top